BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TPM4, P67936, 7171, ENSG00000167460
17 results:

  • 1. Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women.
    Skjerven HK; Myklebust EM; Korvald C; Porojnicu AC; Kaaresen R; Hofvind S; Schlicting E; Sahlberg KK
    Eur J Surg Oncol; 2023 Mar; 49(3):575-582. PubMed ID: 36509629
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Allicin induces cell cycle arrest and apoptosis of breast cancer cells in vitro via modulating the p53 pathway.
    Maitisha G; Aimaiti M; An Z; Li X
    Mol Biol Rep; 2021 Nov; 48(11):7261-7272. PubMed ID: 34626309
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition.
    Tian J; Wang V; Wang N; Khadang B; Boudreault J; Bakdounes K; Ali S; Lebrun JJ
    Breast Cancer Res; 2021 Feb; 23(1):23. PubMed ID: 33588911
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MASTL promotes cell contractility and motility through kinase-independent signaling.
    Taskinen ME; Närvä E; Conway JRW; Hinojosa LS; Lilla S; Mai A; De Franceschi N; Elo LL; Grosse R; Zanivan S; Norman JC; Ivaska J
    J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32311005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling.
    Jeong S; Lim S; Schevzov G; Gunning PW; Helfman DM
    Oncotarget; 2017 May; 8(20):33544-33559. PubMed ID: 28431393
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.
    Dube S; Thomas A; Abbott L; Benz P; Mitschow C; Dube DK; Poiesz BJ
    Oncol Rep; 2016 Jun; 35(6):3143-50. PubMed ID: 27108600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers.
    Pendharkar N; Gajbhiye A; Taunk K; RoyChoudhury S; Dhali S; Seal S; Mane A; Abhang S; Santra MK; Chaudhury K; Rapole S
    J Proteomics; 2016 Jan; 132():112-30. PubMed ID: 26642762
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
    Rebbeck TR; Mitra N; Wan F; Sinilnikova OM; Healey S; McGuffog L; Mazoyer S; Chenevix-Trench G; Easton DF; Antoniou AC; Nathanson KL; ; Laitman Y; Kushnir A; Paluch-Shimon S; Berger R; Zidan J; Friedman E; Ehrencrona H; Stenmark-Askmalm M; Einbeigi Z; Loman N; Harbst K; Rantala J; Melin B; Huo D; Olopade OI; Seldon J; Ganz PA; Nussbaum RL; Chan SB; Odunsi K; Gayther SA; Domchek SM; Arun BK; Lu KH; Mitchell G; Karlan BY; Walsh C; Lester J; Godwin AK; Pathak H; Ross E; Daly MB; Whittemore AS; John EM; Miron A; Terry MB; Chung WK; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Steele L; Neuhausen SL; Ding YC; Ejlertsen B; Gerdes AM; Hansen Tv; Ramón y Cajal T; Osorio A; Benitez J; Godino J; Tejada MI; Duran M; Weitzel JN; Bobolis KA; Sand SR; Fontaine A; Savarese A; Pasini B; Peissel B; Bonanni B; Zaffaroni D; Vignolo-Lutati F; Scuvera G; Giannini G; Bernard L; Genuardi M; Radice P; Dolcetti R; Manoukian S; Pensotti V; Gismondi V; Yannoukakos D; Fostira F; Garber J; Torres D; Rashid MU; Hamann U; Peock S; Frost D; Platte R; Evans DG; Eeles R; Davidson R; Eccles D; Cole T; Cook J; Brewer C; Hodgson S; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Izatt L; Adlard J; Donaldson A; Ellis S; Sharma P; Schmutzler RK; Wappenschmidt B; Becker A; Rhiem K; Hahnen E; Engel C; Meindl A; Engert S; Ditsch N; Arnold N; Plendl HJ; Mundhenke C; Niederacher D; Fleisch M; Sutter C; Bartram CR; Dikow N; Wang-Gohrke S; Gadzicki D; Steinemann D; Kast K; Beer M; Varon-Mateeva R; Gehrig A; Weber BH; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Houdayer C; Belotti M; Gauthier-Villars M; Damiola F; Boutry-Kryza N; Lasset C; Sobol H; Peyrat JP; Muller D; Fricker JP; Collonge-Rame MA; Mortemousque I; Nogues C; Rouleau E; Isaacs C; De Paepe A; Poppe B; Claes K; De Leeneer K; Piedmonte M; Rodriguez G; Wakely K; Boggess J; Blank SV; Basil J; Azodi M; Phillips KA; Caldes T; de la Hoya M; Romero A; Nevanlinna H; Aittomäki K; van der Hout AH; Hogervorst FB; Verhoef S; Collée JM; Seynaeve C; Oosterwijk JC; Gille JJ; Wijnen JT; Gómez Garcia EB; Kets CM; Ausems MG; Aalfs CM; Devilee P; Mensenkamp AR; Kwong A; Olah E; Papp J; Diez O; Lazaro C; Darder E; Blanco I; Salinas M; Jakubowska A; Lubinski J; Gronwald J; Jaworska-Bieniek K; Durda K; Sukiennicki G; Huzarski T; Byrski T; Cybulski C; Toloczko-Grabarek A; Złowocka-Perłowska E; Menkiszak J; Arason A; Barkardottir RB; Simard J; Laframboise R; Montagna M; Agata S; Alducci E; Peixoto A; Teixeira MR; Spurdle AB; Lee MH; Park SK; Kim SW; Friebel TM; Couch FJ; Lindor NM; Pankratz VS; Guidugli L; Wang X; Tischkowitz M; Foretova L; Vijai J; Offit K; Robson M; Rau-Murthy R; Kauff N; Fink-Retter A; Singer CF; Rappaport C; Gschwantler-Kaulich D; Pfeiler G; Tea MK; Berger A; Greene MH; Mai PL; Imyanitov EN; Toland AE; Senter L; Bojesen A; Pedersen IS; Skytte AB; Sunde L; Thomassen M; Moeller ST; Kruse TA; Jensen UB; Caligo MA; Aretini P; Teo SH; Selkirk CG; Hulick PJ; Andrulis I
    JAMA; 2015 Apr; 313(13):1347-61. PubMed ID: 25849179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mammographic compression--a need for mechanical standardization.
    Branderhorst W; de Groot JE; Highnam R; Chan A; Böhm-Vélez M; Broeders MJ; den Heeten GJ; Grimbergen CA
    Eur J Radiol; 2015 Apr; 84(4):596-602. PubMed ID: 25596915
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis.
    Singleton DC; Rouhi P; Zois CE; Haider S; Li JL; Kessler BM; Cao Y; Harris AL
    Oncogene; 2015 Sep; 34(36):4713-22. PubMed ID: 25486436
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.
    Gach PC; Attayek PJ; Whittlesey RL; Yeh JJ; Allbritton NL
    Biosens Bioelectron; 2014 Apr; 54():476-83. PubMed ID: 24316450
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.
    Mihály Z; Kormos M; Lánczky A; Dank M; Budczies J; Szász MA; Győrffy B
    Breast Cancer Res Treat; 2013 Jul; 140(2):219-32. PubMed ID: 23836010
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.
    Mendes-Pereira AM; Sims D; Dexter T; Fenwick K; Assiotis I; Kozarewa I; Mitsopoulos C; Hakas J; Zvelebil M; Lord CJ; Ashworth A
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2730-5. PubMed ID: 21482774
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential.
    Tot T; Pekár G; Hofmeyer S; Sollie T; Gere M; Tarján M
    Virchows Arch; 2009 Aug; 455(2):109-15. PubMed ID: 19621241
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.
    Li R; Morris SW
    Med Res Rev; 2008 May; 28(3):372-412. PubMed ID: 17694547
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
    Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
    Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.